FP-101

FP-101 is an extended-release, orally dosed, non-hormonal, non-herbal, non-antidepressant small molecule drug developed by Fervent Pharmaceuticals for the treatment of vasomotor symptoms associated with menopause, such as hot flashes and night sweats. The compound has a known mechanism of action and is already FDA-approved for another undisclosed indication. It is being repurposed for menopausal symptoms using an expedited regulatory pathway due to its established safety profile in other uses. Clinical trials have demonstrated promising efficacy in reducing vasomotor symptoms in peri- and post-menopausal women[1][2][3][5][7][8].